The Vitreoretinal unit has a long history and contribution to
Indian Ophthalmology. To begin with it was headed by Prof. P.K.
Khosla and later by Prof. H.K. Tiwari in the past. The unit has
been engaged in high quality patient care, teaching and training
through residency programme and involved in research through
various intra and extra mural projects. The unit has contributed
considerably in the field of central serous retinopathy, branch
vein occlusion, retinal detachment surgery and Eale’s disease.
Important internationally quoted research work in the past
include production of experimental model of diabetic retinopathy,
experimental studies on toxoplasmosis, role of stress in central
serous retinopathy and effect of perforation of sclera on retina
layers during strabismus surgery
Vitreoretina is a
dynamic ophthalmic specialty and multiple diagnostic and
therapeutic modalities have come in the last few years. The
Vitreoretina unit is well equipped with the latest surgical
equipments to deal with advanced vitreoretinal surgery procedures.
The regular usage of wide angle viewing systems, finer
microsurgical instruments and small gauge vitrectomy has
revolutionized the way we do vitreoretinal surgery. The centre
provides world class medical and surgical care at economical
prices. Many patients with complicated vitreoretinal problems are
routinely referred to this centre and successfully managed by top
vitreoretinal experts available for consultation. The retina labs
are well equipped with the modern diagnostic equipment to
correctly identify and treat vitreoretinal diseases. Priced
economically, the centre caters to the referral needs of the vast
population. Easy availability of digital fluorescein angiography
systems, advanced posterior segment lasers, Ocular coherence
tomography, Retcam, and top electrophysiological testing tools -
enable us to identify and treat in a timely manner.
We are a top
referral centre for early diagnosis and management of retinopathy
of prematurity, a potentially blinding disease of premature
babies. Research is underway into usage of stem cells for treating
retinal disease, anti VEGF drugs for macular degeneration and
genetic studies for treating common retinal diseases. The
department regularly propagates emerging trends in management of
retinal disease worldwide via active teaching modules, publishing
research in indexed journals, international invited faculty
lectures, instruction courses, in house training, specialty
clinics and participation of our faculty in national and
international conferences.
It is the apex
organization in the country for research, training and management
of vitreoretinal diseases and we continue to attempt to better
ourselves.
Sub-specialties
Provided by the Department
.
main
